Literature DB >> 8703660

Effects of azapropazone on pain-related brain activity in human subjects.

J Lötsch1, P Mohammadian, T Hummel, S Florin, K Brune, G Geisslinger, G Kobal.   

Abstract

1. The dose-related effects of azapropazone on (i) event-related and spontaneous EEG-activity and (ii) the subjects' pain ratings were investigated using an experimental human pain model based on both chemo-somatosensory event-related potentials (CSSERP) and subjects' pain ratings. 2. Healthy subjects (n = 20) participated in a placebo-controlled, randomized, double-blind, four-way cross-over study. Single doses of azapropazone (300 mg, 600 mg and 1200 mg) and placebo were administered intravenously. Each experiment consisted of five sessions (before and 1, 2, 4 and 8 h after administration of the medication). Each session lasted for approximately 40 min. In the first 20 min, pain was induced by short CO2-stimuli presented to the right nostril (phasic pain; interstimulus interval 30 s) and EEG was recorded from five positions. CSSERPs were obtained in response to painful CO2-stimuli. In the following 20 min period, tonic pain was induced by a constant stream of dry air introduced in the left nostril. Subjects rated the intensity of both phasic and tonic pain by means of a visual analogue scale. Additionally, a frequency analysis of the spontaneous EEG was performed. 3. Azapropazone reduced the pain-related CSSERP-amplitudes at frontal and parietal recording positions. This topographical pattern was observed in previous studies with opioids, while NSAIDs such as flurbiprofen and ketoprofen exerted effects at frontal and central positions. In contrast to other NSAIDs, administration of azapropazone resulted in a reduction of the frequency bands alpha 1, delta and theta of the spontaneous EEG. At the subjective level, analgesic effects of azapropazone were observed in the ratings of tonic pain. 4. Analgesic properties of azapropazone were demonstrated in man. The topographical pattern of the changes in the CSSERPs and the effects on EEG background activity suggest a central component of the analgesic action of azapropazone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8703660      PMCID: PMC1365209          DOI: 10.1111/j.1365-2125.1995.tb05799.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  25 in total

1.  Cerebral responses to electrical tooth pulp stimulation in man. An objective correlate of acute experimental pain.

Authors:  G E Chatrian; R C Canfield; T A Knauss; E L Eegt
Journal:  Neurology       Date:  1975-08       Impact factor: 9.910

2.  Cortical responses to painful CO2 stimulation of nasal mucosa; a magnetoencephalographic study in man.

Authors:  J Huttunen; G Kobal; E Kaukoranta; R Hari
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1986-10

3.  Effects of flupirtine on the pain-related evoked potential and the spontaneous EEG.

Authors:  G Kobal; T Hummel
Journal:  Agents Actions       Date:  1988-02

4.  Concentration of azapropazone in synovial tissues and fluid.

Authors:  H Spahn; K Thabe; E Mutschler; K Tillmann; I Gikalov
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  The determination of azapropazone and its 6-hydroxy metabolite in plasma and urine by HPLC.

Authors:  B J Kline; J H Wood; L A Beightol
Journal:  Arzneimittelforschung       Date:  1983

6.  Tooth pulp-evoked potentials in the monkey: cortical surface and intracortical distribution.

Authors:  Eric H Chudler; Willie K Dong; Yoriko Kawakami
Journal:  Pain       Date:  1985-07       Impact factor: 6.961

7.  Pain-related electrical potentials of the human nasal mucosa elicited by chemical stimulation.

Authors:  G Kobal
Journal:  Pain       Date:  1985-06       Impact factor: 6.961

8.  A sensitive method to evaluate effects of analgesics in man.

Authors:  B Bromm; E Scharein
Journal:  Methods Find Exp Clin Pharmacol       Date:  1983-10

9.  Evoked cerebral potential correlates of C-fibre activity in man.

Authors:  B Bromm; H Neitzel; A Tecklenburg; R D Treede
Journal:  Neurosci Lett       Date:  1983-12-23       Impact factor: 3.046

10.  Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects.

Authors:  J Lötsch; G Geisslinger; P Mohammadian; K Brune; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

View more
  5 in total

1.  Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: relation to pharmacodynamics in an experimental pain model.

Authors:  J Lötsch; B Kettenmann; B Renner; D Drover; K Brune; G Geisslinger; G Kobal
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

2.  A novel approach to pharmaco-EEG for investigating analgesics: assessment of spectral indices in single-sweep evoked brain potentials.

Authors:  Mikkel Gram; Carina Graversen; Anders K Nielsen; Thomas Arendt-Nielsen; Carsten D Mørch; Trine Andresen; Asbjørn M Drewes
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

Review 3.  Electroencephalography and analgesics.

Authors:  Lasse Paludan Malver; Anne Brokjaer; Camilla Staahl; Carina Graversen; Trine Andresen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

4.  Tonic stimulation of the pharyngeal mucosa causes pain and a reversible increase of inflammatory mediators.

Authors:  Bertold Renner; Gabi Ahne; Elke Grosan; Birgit Kettenmann; Gerd Kobal; Adrian Shephard
Journal:  Inflamm Res       Date:  2013-09-15       Impact factor: 4.575

5.  [Effect of pre-administered flurbiprofen axetil on the EC50 of propofol during anesthesia in unstimulated patients: a randomized clinical trial].

Authors:  Jing Ma; Mian Peng; Fei Wang; Lei Chen; Zong-Ze Zhang; Yan-Lin Wang
Journal:  Braz J Anesthesiol       Date:  2020-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.